Immunomodulatory peptide from cystatin, a natural cysteine protease inhibitor, against leishmaniasis as a model macrophage disease

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 5, 2007, Pages 1700-1707

  Mukherjee, Snigdha ^a   Ukil, Anindita ^a   Das, Pijush K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5,6 DIHYDRO 6 METHYL 4H 1,3 THIAZINE; COMPLEMENTARY DNA; CYSTATIN; CYSTEINE PROTEINASE INHIBITOR; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; SYNTHETIC PEPTIDE; THIAZINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISSECTION; ENZYME INHIBITION; IC 50; INFECTION RESISTANCE; INHIBITION KINETICS; LEISHMANIASIS; LIVER; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; INTERLEUKIN-12; LEISHMANIASIS, VISCERAL; MACROPHAGES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; PEPTIDE FRAGMENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248370089     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01555-06     Document Type: Article

References (28)

1. Abrahamson, M., A. J. Barrett, G. Salvesen, and A. Grubb. 1986. Isolation of six cysteine proteinase inhibitors from human urine. Their physico-chemical and enzyme kinetic properties and concentrations in biological fluids. J. Biol. Chem. 261:11282-11289.
2. Bandyopadhyay, K., S. Karmakar, A. Biswas, and P. K. Das. 2003. Membrane orientation of laminin binding protein: an extracellular matrix bridging molecule of Leishmania donovani. Eur. J. Biochem. 270:3806-3813.
3. Bjorck, L., A. Grubb, and L. Kjellen. 1990. Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J. Virol. 64:941-943.
4. Blankenvoore, M. F., W. van't Hof, E. Walgreen-Weterings, T. J. van Steenbergen, H. S. Brand, E. C. Veerman, and A. V. Nieuw Ameronge. 1998. Cystatin and cystain-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis. Biol. Chem. 379:1371-1375.
5. Collins, A. R., and A. Grubb. 1991. Inhibitory effects of recombinant human cystatin C on human coronaviruses. Antimicrob. Agents Chemother. 35: 2444-2446.
6. Das, L., N. Datta, S. Bandhopadhyay, and P. K. Das. 2001. Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J. Immunol. 166:4020-4028.
7. Edwards, R. J., A. M. Singleton, A. R. Boobis, and D. S. Davies. 1989. Cross-reaction of antibodies to coupling groups used in the production of anti-peptide antibodies. J. Immunol. Methods 117:215-220.
8. Facchetti, F., W. Vermi, S. Fiorentini, M. Chilosi, A. Caruso, M. Duse, L. D. Notarangelo, and R. Badolato. 1999. Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions. Am. J. Pathol. 154:145-152.
9. Finkelman, F. D., and J. F. Urban. 1992. Cytokines: making the right choice. Parasitol. Today 8:311-314.
10. Gantt, K. R., T. L. Goldman, M. L. McCormick, M. A. Miller, S. M. B. Jeronimo, E. T. Nascimento, B. E. Britigan, and M. E. Wilson. 2001. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 167:893-901.
11. Grubb, A, and H. Löfberg. 1982. Human α-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc. Natl. Acad. Sci. USA 79:3024-3027.
12. Gullick, W. J. 1994. Production of antisera to synthetic peptides. Methods Mol. Biol. 32:389-399.
13. Hall, A., K. Hakansson, R. W. Mason, A. Grubb, and M. Abrahamson. 1995. Structural basis for the biological specificity of cystatin C. Identification of Leu-9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. J. Biol. Chem. 270:5115-5121.
14. Hall, A., H. Dalboge, A. Grubb, and M. Abrahamson. 1993. Importance of evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition. Biochem. J. 291: 123-129.
15. Hall, D. E., K. A. Frazeer, B. C. Hann, and L. F. Reichardt. 1988. Isolation and characterization of a laminin-binding protein from rat and chick muscle. J. Cell Biol. 107:687-697.
16. Handerson, P. J. F. 1972. A linear equation that describes the steady state kinetics of enzyme and subcellular particles interacting with tightly bound inhibitors. Biochem. J. 127:321-333.
17. Ilg, T., M. Fuchs, V. Gnau, M. Wolfram, D. Harbecke, and P. Overath. 1994. Distribution of parasite cysteine proteinases in lesions of mice infected with Leishmania mexicana amastigotes. Mol. Biochem. Parasitol. 67:193-203.
18. Machleidt, W., U. Thiele, M. Assfalg, A. Esterl, G. Wiegand, J. Kos, V. Turk, and W. Bode. 1989. Mechanism of inhibition of papain by chicken egg white cystatin. Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments, of the inhibitor. FEBS Lett. 243:234-238.
19. Mottram, J. C., D. R. Brooks, and G. H. Coombs. 1998. Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr. Opin. Microbiol. 1:455-460.
20. Mottram, J. C., A. E. Souza, J. E. Hutchison, R. Carter, M. J. Frame, and G. H. Coombs. 1996. Evidence from disruption of the Imcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc. Natl. Acad. Sci. USA 93:6008-6013.
21. Murray, H. W., G. D. Miralles, M. Y. Stoeckle, and D. F. McDermott. 1993. Role and effect of 1L-2 in experimental visceral leishmaniasis. J. Immunol. 151:929-938.
22. Nicklin, M. J. H., and A. J. Barrett. 1984. Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg white cystatin. Biochem. J. 223:245-253.
23. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1994. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor required as costimulatory factor for interferon-induced activation. Proc. Natl. Acad. Sci. USA 89:8676-8680.
24. Qadoumi, M., I. Becker, N. Donhauser, M. Rollinghoff, and C. Bogdan. 2002. Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis. Infect. Immun. 70:4638-4642.
25. Sarkar, K., and P. K. Das. 1997. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines. J. Immunol. 158:5357-5365.
26. Verdot, L., G. Lalmanach, V. Vercruysse, S. Hartmann, R. Lucius, J. Hoebeke, F. Gauthier, and B. Vray. 1996. Cystatins up-regulate nitric oxide release from interferon-activated mouse peritoneal macrophages. J. Biol. Chem. 271:28077-28081.
27. Vray, B., S. Hartmann, and J. Hoebele. 2002. Immunomodulatory properties of cystatins. Cell. Mol. Life Sci. 59:1503-1512.
28. Weiczerzak, E., P. Drabik, L. Lankiewicz, S. Oldziej, Z. Gizonka, M. Abrahamson, A Grubb, and D. Bromine. 2002. Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases. J. Med. Chem. 45:4202-4211.